Analysis and results of the recombinant factor VIIa extended-use registry

This paper describes the analysis of recombinant factor VIIa (rFVIIa; NovoSeven; Novo Nordisk, Bagsvaerd, Denmark) use in 40 patients with intractable bleeding in the UK. All cases were reported on the 'rFVIIa extended use database' (Traumanet) between its launch in February 1999 and 12 Ma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood coagulation & fibrinolysis 2003-06, Vol.14 Suppl 1 (SUPPLEMENT 1), p.S35-S38
Hauptverfasser:	Laffan, Michael, O'Connell, Niamh M, Perry, David J, Hodgson, Andrew J, O'Shaughnessy, Denise, Smith, Owen P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antifibrinolytic Agents - administration & dosage Antifibrinolytic Agents - therapeutic use Comorbidity Factor VII - administration & dosage Factor VII - adverse effects Factor VII - therapeutic use Factor VIIa Female Hemorrhage - drug therapy Hemorrhage - epidemiology Hemostatics - administration & dosage Hemostatics - adverse effects Hemostatics - therapeutic use Humans Ireland - epidemiology Male Middle Aged Recombinant Proteins - administration & dosage Recombinant Proteins - adverse effects Recombinant Proteins - therapeutic use Registries - statistics & numerical data Safety Thrombophilia - complications Thrombosis - chemically induced Thrombosis - etiology Treatment Outcome United Kingdom - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!